Notably, semaglutide and exenatide showed higher NAE proportions (16.97% and 14.44%, respectively) compared to tirzepatide (6.06%)
This will be discussed prior to proceeding with the treatment
Skip to main content Advertisement Advertisement Advertisement Advertisement Turn static files into dynamic content formats
It is a dual agonist of GLP-1 and GIP receptors to help regulate blood sugar levels and reduce appetite to improve glycemic control and support weight loss in patients with chronic conditions
Popular GLP-1 medications used to treat type 2 diabetes and obesitysemaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound)may be linked to a small increase in the risk of a rare eye condition that can cause sudden vision loss, according to new research
What Studies Show In a Phase 2 clinical trial published in The Lancet Diabetes & Endocrinology , patients taking survodutide experienced meaningful, dose-dependent weight loss